Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. 1998

A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
Department of Microbiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories.

Coccidioidomycosis is endemic in regions of the Americas, but this infection may be encountered in travellers who return from an endemic region. A case is reported of a disseminated infection in a Hong Kong Chinese man, who was successfully treated with amphotericin B lipid complex (ABLC) after intolerance and toxicity precluded the use of other antifungal agents. Lipid-based formulations of amphotericin B merit further evaluation in the treatment of coccidioidomycosis and other systemic mycoses.

UI MeSH Term Description Entries
D008297 Male Males
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D010715 Phosphatidylglycerols A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis. Glycerol Phosphoglycerides,Monophosphatidylglycerols,Phosphatidylglycerol,Phosphatidyl Glycerol,Glycerol, Phosphatidyl,Phosphoglycerides, Glycerol
D003047 Coccidioidomycosis Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN. Coccidioides Infection,Coccidioides posadasii Infection,Coccidioidomycosis Infection,Coccidioides immitis Infection,San Joaquin Valley Fever,Valley Fever,Coccidioides Infections,Coccidioides immitis Infections,Coccidioides posadasii Infections,Coccidioidomycoses,Coccidioidomycosis Infections,Infection, Coccidioides,Infection, Coccidioides immitis,Infection, Coccidioides posadasii,Infection, Coccidioidomycosis,Valley Fevers
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
April 1977, Chest,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
October 1959, New York state journal of medicine,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
October 1958, United States Armed Forces medical journal,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
May 1958, Journal of the American Medical Association,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
February 1957, California medicine,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
July 1958, A.M.A. archives of dermatology,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
April 1960, The American review of respiratory disease,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
April 1962, Annals of internal medicine,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
September 1992, The Journal of antimicrobial chemotherapy,
A P Koehler, and A F Cheng, and K C Chu, and C H Chan, and A S Ho, and D J Lyon
January 2000, The Journal of infection,
Copied contents to your clipboard!